Cancer clinical trials in the region Grand Est

218 currently recruiting clinical trials
Region Grand Est

Phase 3 Colon cancer Rectal cancer #NCT06107920 #2024-516456-17-00
Adenocarcinoma Localized MSS/pMMR None Surgery Chemotherapy Radiotherapy
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy), Centre Hospitalier de Colmar (Colmar), Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Hôpital universitaire de Rouen
Phase 3 Breast cancer #NCT06435429
HER2 Positive Locally Advanced Metastatic 1 2 3 or more Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
Jazz Pharmaceuticals
Phase 3 Lung cancer #NCT07190248 #2024-514500-14-00
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced Metastatic KRAS G12C Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
Merck Sharp & Dohme LLC
Phase 3 Breast cancer #NCT06103864 #2023-503675-24-00
HER2 Negative HR Negative Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
AstraZeneca
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT03772028 #2023-509049-11-00
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Locally Advanced None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Strasbourg - Nouvel Hopital Civil (Strasbourg)
Phase 3 Breast cancer #NCT06103864 #2023-503675-24-00
HER2 Negative HR Negative Locally Advanced PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%)
CHRU de Nancy - Hôpitaux de Brabois (Vandœuvre-lès-Nancy)
AstraZeneca
Phase 3 Lung cancer #NCT06203210
SCLC (Small Cell Lung Cancer) 1 Chemotherapy Chemotherapy
Ghrmsa - Hôpital Emile Muller (Mulhouse)
Daiichi Sankyo
Phase 3 Ovarian / Fallopian tubes / Peritoneum cancer #NCT03842982 #2018-003680-62
Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Serous high grade carcinoma (HGSOC) Endometrioid carcinoma Clear cell carcinoma Mucinous carcinoma Stage III Locally Advanced 1 2 3 or more Systemic Treatment-Naive
Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), Hôpital de Hautepierre - Hôpitaux Universitaires de Strasbourg (Strasbourg)
Centre Oscar Lambret
Phase 3 Endometrial cancer #NCT06340568 #2023-507525-42-00
Endometrioid adenocarcinoma Serous adenocarcinoma Clear cell carcinoma Dedifferentiated and undifferentiated endometrial ... Carcinosarcoma Locally Advanced Metastatic HER2 None 1 Immunotherapy Chemotherapy Systemic Treatment-Naive Immunotherapy Chemotherapy
Antibody Drug Conjugates (ADC) Antibody Drug Conjugates (ADC)
ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg)
BioNTech SE
Phase 3 Lung cancer #NCT06422143 #2023-510128-66-00
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Metastatic None Systemic Treatment-Naive
Immunotherapy Antibody Drug Conjugates (ADC) Immunotherapy Antibody Drug Conjugates (ADC)
Hôpital Robert Schuman - UNEOS (Vantoux)
Merck Sharp & Dohme LLC